ID   WIF-B9/Rev
AC   CVCL_A5BL
SY   WI-38/Fao hybrid-B9/Revertant
DR   Wikidata; Q107117448
RX   PubMed=17276572;
CC   Characteristics: Established by culturing the parent cell line without cisplatin in the medium for 2 months.
CC   Doubling time: 2.7 +- 0.1 days (PubMed=17276572).
CC   Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_A5BK ! WIF-B9/R
CA   Hybrid cell line
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
RX   PubMed=17276572; DOI=10.1016/j.tox.2006.12.022;
RA   Briz O., Cassio D., Blazquez A.G., Grosse B., Serrano M.A.,
RA   Marin J.J.G.;
RT   "Characterization of WIF-B9/R cells as an in vitro model with
RT   hepatocyte-like polarity and enhanced expression of canalicular ABC
RT   transporters involved in phase III of hepatic detoxification.";
RL   Toxicology 232:24-36(2007).
//